GSK partner Hansoh reports another phase 3 win for priority ADC July 28, 2026Posted inBiotechnology Hansoh Pharmaceutical has guided its GSK-partnered, B7-H3-directed antibody-drug conjugate to another phase 3 win in China. Post navigation Previous Post Clonal Division Memory in Humans Splits Between Healthy Blood Formation and AMLNext PostGuardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
